Both programs aim to help with weight loss but differ in their approach, features, and pricing
Participants were randomly assigned to once-weekly semaglutide 20 mg (n=480 [50%]) or 10 mg (n=481 [50%])
Patients taking the higher dose experienced an average weight loss of 20.7% compared to about 16% on the standard dose, the doctor noted
Acknowledgements This work was funded by grants from the Yunnan University Medical Research Foundation Department of Radiology (Grant No
Patients with type 2 diabetes and elevated inflammatory markers, particularly those with established cardiovascular disease or high cardiovascular risk, represent a group where GLP-1 receptor agonists are already recommended by the ADA and American College of Physicians (ACP)
Individuals in Durango with a BMI of 30 or higher, or a BMI of 27 with conditions like hypertension, type 2 diabetes, or elevated cholesterol may qualify as good candidates for semaglutide treatment